Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devy Zisman

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The Journal of Rheumatology|February 9, 2018
Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter StudyLihi Eder, Paula Harvey, Vinod Chandran, et al.
The Journal of Rheumatology|November 1, 2023
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent ControlsTali Eviatar, Victoria Furer, Ari Polachek, et al.
The Israel Medical Association Journal : IMAJ|April 10, 2018
Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid ArthritisMahmoud Abu-Shakra, Devy Zisman, Alexandra Balbir-Gurman, et al.
The Journal of Rheumatology|June 17, 2020
Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic ArthritisJustine Maller, Emily Fox, K T Park, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
The Journal of Rheumatology|November 1, 2022
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment RecommendationsCristiano B Campanholo, Ajesh B Maharaj, Nadia Corp, et al.
Vaccines|June 24, 2022
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with RituximabVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Vaccines|May 5, 2021
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 VaccinationAbdulla Watad, Gabriele De Marco, Hussein Mahajna, et al.
Annals of the Rheumatic Diseases|June 15, 2021
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre studyVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Frontiers in Immunology|March 30, 2023
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinationsFadi Kharouf, Tali Eviatar, Maya Braun, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The Journal of Rheumatology|February 9, 2018
Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter StudyLihi Eder, Paula Harvey, Vinod Chandran, et al.
The Journal of Rheumatology|November 1, 2023
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent ControlsTali Eviatar, Victoria Furer, Ari Polachek, et al.
The Israel Medical Association Journal : IMAJ|April 10, 2018
Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid ArthritisMahmoud Abu-Shakra, Devy Zisman, Alexandra Balbir-Gurman, et al.
The Journal of Rheumatology|June 17, 2020
Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic ArthritisJustine Maller, Emily Fox, K T Park, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
The Journal of Rheumatology|November 1, 2022
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment RecommendationsCristiano B Campanholo, Ajesh B Maharaj, Nadia Corp, et al.
Vaccines|June 24, 2022
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with RituximabVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Vaccines|May 5, 2021
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 VaccinationAbdulla Watad, Gabriele De Marco, Hussein Mahajna, et al.
Annals of the Rheumatic Diseases|June 15, 2021
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre studyVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Frontiers in Immunology|March 30, 2023
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinationsFadi Kharouf, Tali Eviatar, Maya Braun, et al.
Pageof 8